Find an Article

Filter articles

Showing 2341 to 2350 of 2354 results

Pharmaceutical patent owners on alert

Brazil30-11-2009Otto Licks and Marcela de Souza

New law enacted by President Lula and two leading cases currently pending before Brazil’s highest courts may leave blockbuster drugs without patent protection in Brazil, say Otto Licks and Marcela de Souza.

Moral and ethical questions for patenting genetic material

Israel30-11-2009Dr. Michael Factor and Dr. Moshe Tritel

The use of embryonic stem cells to develop medical treatments is a controversial topic. Michael Factor and Moshe Tritel look at the situation in Israel.

Clarifying patentability for medical and surgical developments

EU30-11-2009Annelise Holme

Two recent Enlarged Board of Appeal decisions provide new guidelines on how to interpret the extent of exceptions to patentability before the European Patent Office, says Annelise Holme.

A big step: Colombia's accession to the OECD

Colombia01-09-0000Ernesto Cavelier

With Colombia’s accession to the Organization for Economic Development comes a raft of intellectual property changes, as Ernesto Cavelier explains.

In the house: a partial solution

International01-09-0000Clémence Le Cointe

With the new generic top-level domains imminent, Clémence Le Cointe asks whether the Trademark Clearinghouse is a helpful tool for brand owners.

Raising the bar: meeting WTO obligations

Russia01-05-0000Elena Solovyova

Now that it is a member of the World Trade Organization, Russia must lift its game against the counterfeiters and pirates. Elena Solovyova finds out what progress has been made and where Russia is falling short.

How to play by the UPC rules

EU30-11--0001Paul England and Christopher Thornham

The rules of procedure for the Unified Patent Court, as agreed in October 2015, are very important and have been carefully constructed. Paul England and Christopher Thornham of Taylor Wessing explain what they mean for litigation in the new system.

Presenting previously cited prior art in a re-examination

Gregory Novak

Gregory Novak looks at the options for using previously cited prior art in patent re-examinations.

Patent restoration: standard of reasonable care

In a hearing before the Singapore Registrar of Patents in 2009, Advanced Systems Automation Ltd. filed applications for restoration of its 12 patents between 10 and 29 months after the patent renewal due dates.

EPO oppositions: A cost-effective alternative to litigation

Philip Thomas and Tony Proctor

An opposition at the European Patent Office (EPO) is the only way to challenge the validity of a European patent centrally. Philip Thomas and Tony Proctor look at why it's a better option than national proceedings.

Showing 2341 to 2350 of 2354 results


Service Providers

Batavia Patentservis Asia (formerly Batavia Patent Agent)

Park IP Translations
Park IP is your trusted partner for legal language solutions

Practice Insight
Get the Information Edge with Practice Insight

Trademark Research Tools & Watching Services, Watching Services

Law Firms

Patentbüro Paul Rosenich AG
Europe, Switzerland, Liechtenstein

Bury & Bury European and Polish Patent and Trademark Attorneys
European Union, European Patent Organisation, Poland

Henry Goh & Co Sdn Bhd
Malaysia, Singapore, Brunei

Grup Ofis Marka Patent A.S

Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Panama and Dominican Republic (Costa Rica, head office)

Mikhailyuk Sorokolat & Partners
Ukraine, Russia, Kazakhstan, Belarus, Georgia, Uzbekistan, Moldova